BioSpace News Archive

Deals

China Medical Technologies, Inc. Announces the Sale of its HIFU Business to a Major Shareholder, Chengxuan International for $53.5 Million in Cash

December 18, 2008
·
5 min read
Policy

EpiDerm’s Skin Irritation Test Fully Validated in European Union

December 18, 2008
·
2 min read
Drug Development

Chugai Pharmaceutical Co., Ltd. (Japan) and Taisho Pharmaceutical Release: Eldecalcitol, an Active Vitamin D3 Derivative, Reduces Incidence of New Vertebral Fractures in Osteoporosis Patients in Phase III Clinical Trial

December 18, 2008
·
1 min read
Business

Entra Pharmaceuticals Raises $4.23 Million in First Round

December 18, 2008
·
1 min read
Drug Development

GlaxoSmithKline (JOBS) Places Big Bet on Drug for Clogged Arteries

December 18, 2008
·
1 min read
Business

Ligand Pharmaceuticals Inc. Enters into Exclusive License Agreement with GlaxoSmithKline (JOBS) to License Rights to LGD-4665 and other Ligand Thrombopoietin (TPO) Molecules; GlaxoSmithKline will Pay Up to $158 Million

December 18, 2008
·
4 min read
Business

DSM Biologics and Crucell N.V. Announce PER.C6(R) Research License Agreement with GlaxoSmithKline

December 18, 2008
·
4 min read
Business

DSM Biologics And Crucell N.V. Announce PER.C6(R) Research License Agreement with GlaxoSmithKline

December 18, 2008
·
1 min read
Deals

Genmab, Inc. Sells Arzerra Co-Promotion Rights to GlaxoSmithKline; Genmab will Receive a One-time Payment of $4.5M from GSK Upon the FDA’s Acceptance for Review of the Filing of the First BLA for Ofatumumab

December 18, 2008
·
1 min read